Quercetin and Nano-Derivatives: Potential and Challenges in Cancer Therapy

Xin-Ru Li,1 Lin Qi,2 Xi-Wen Zhang,3 Chao Wei,1 Bin Yu,1 Tian-Li Pei4 1College of Integrated Chinese and Western Medicine, Jining Medical University, Jining, Shandong Province, 272000, People’s Republic of China; 2Affiliated Hospital of Jining Medical University, Jining, 272000, People’s Republic of China; 3College of The Second Clinical Medical, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, 450003, People’s Republic of China; 4Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Province, 550000, People’s Republic of ChinaCorrespondence: Tian-Li Pei, Email [email protected]: Quercetin, a prevalent flavonol compound, has gained attention for its multifaceted mechanisms of action against various cancers, highlighting its potential as an adjunctive therapy in cancer treatments. This review aims to systematically evaluate the structural optimization, mechanisms of action, and clinical applications of quercetin and its nano-derivatives in cancer treatment. Employing a bibliometric analysis of 6231 articles from the Web of Science Core Collection, we observed a notable increase in annual publications, particularly from the USA and China, indicating a growing interest in quercetin’s therapeutic potential. Our findings reveal that quercetin enhances the efficacy of conventional therapies by modulating critical signaling pathways, thereby increasing cancer cell sensitivity while simultaneously protecting normal tissues from therapy-induced damage. Structural modifications, including glycosylation, methylation, sulfation, and glucuronidation, alongside nanoparticle formulation, significantly improve the stability, solubility, and bioavailability of quercetin, enabling targeted drug delivery. Despite the promising preclinical outcomes, the clinical translation of quercetin remains nascent, necessitating further rigorous research to validate its safety and efficacy in human subjects. In conclusion, while quercetin exhibits substantial anticancer properties and therapeutic potential, future studies should focus on expanding sample sizes, elucidating metabolic pathways, and conducting comprehensive clinical trials to inform its application in oncology.Keywords: quercetin, nano-derivatives, cancer therapy, mechanisms of action, drug safety

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-05-01
Primary Topic
Particle Detector Development and Performance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quercetin and Nano-Derivatives: Potential and Challenges in Cancer Therapy

SHILAP Revista de lepidopterología
Particle Detector Development and Performance
article

Quercetin and Nano-Derivatives: Potential and Challenges in Cancer Therapy

article en

Abstract

Xin-Ru Li,1 Lin Qi,2 Xi-Wen Zhang,3 Chao Wei,1 Bin Yu,1 Tian-Li Pei4 1College of Integrated Chinese and Western Medicine, Jining Medical University, Jining, Shandong Province, 272000, People’s Republic of China; 2Affiliated Hospital of Jining Medical University, Jining, 272000, People’s Republic of China; 3College of The Second Clinical Medical, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, 450003, People’s Republic of China; 4Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Province, 550000, People’s Republic of ChinaCorrespondence: Tian-Li Pei, Email [email protected]: Quercetin, a prevalent flavonol compound, has gained attention for its multifaceted mechanisms of action against various cancers, highlighting its potential as an adjunctive therapy in cancer treatments. This review aims to systematically evaluate the structural optimization, mechanisms of action, and clinical applications of quercetin and its nano-derivatives in cancer treatment. Employing a bibliometric analysis of 6231 articles from the Web of Science Core Collection, we observed a notable increase in annual publications, particularly from the USA and China, indicating a growing interest in quercetin’s therapeutic potential. Our findings reveal that quercetin enhances the efficacy of conventional therapies by modulating critical signaling pathways, thereby increasing cancer cell sensitivity while simultaneously protecting normal tissues from therapy-induced damage. Structural modifications, including glycosylation, methylation, sulfation, and glucuronidation, alongside nanoparticle formulation, significantly improve the stability, solubility, and bioavailability of quercetin, enabling targeted drug delivery. Despite the promising preclinical outcomes, the clinical translation of quercetin remains nascent, necessitating further rigorous research to validate its safety and efficacy in human subjects. In conclusion, while quercetin exhibits substantial anticancer properties and therapeutic potential, future studies should focus on expanding sample sizes, elucidating metabolic pathways, and conducting comprehensive clinical trials to inform its application in oncology.Keywords: quercetin, nano-derivatives, cancer therapy, mechanisms of action, drug safety

SHILAP Revista de lepidopterología
Openalex Percentile: Top 61%
Particle Detector Development and Performance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.